Jiangsu Nanfang Medical (603880) - Net Assets

Latest as of September 2025: CN¥259.57 Million CNY ≈ $37.98 Million USD

Based on the latest financial reports, Jiangsu Nanfang Medical (603880) has net assets worth CN¥259.57 Million CNY (≈ $37.98 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥993.46 Million ≈ $145.37 Million USD) and total liabilities (CN¥733.89 Million ≈ $107.39 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 603880 financial resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥259.57 Million
% of Total Assets	26.13%
Annual Growth Rate	7.35%
5-Year Change	-59.42%
10-Year Change	27.82%
Growth Volatility	35.78

Jiangsu Nanfang Medical - Net Assets Trend (2012–2024)

This chart illustrates how Jiangsu Nanfang Medical's net assets have evolved over time, based on quarterly financial data. Also explore 603880 asset base for the complete picture of this company's asset base.

Annual Net Assets for Jiangsu Nanfang Medical (2012–2024)

The table below shows the annual net assets of Jiangsu Nanfang Medical from 2012 to 2024. For live valuation and market cap data, see 603880 stock market capitalisation.

Year	Net Assets	Change
2024-12-31	CN¥284.41 Million ≈ $41.62 Million	-40.03%
2023-12-31	CN¥474.22 Million ≈ $69.39 Million	-23.70%
2022-12-31	CN¥621.48 Million ≈ $90.94 Million	-5.10%
2021-12-31	CN¥654.90 Million ≈ $95.83 Million	-6.55%
2020-12-31	CN¥700.80 Million ≈ $102.55 Million	+23.48%
2019-12-31	CN¥567.52 Million ≈ $83.05 Million	+1.34%
2018-12-31	CN¥560.04 Million ≈ $81.95 Million	+4.18%
2017-12-31	CN¥537.57 Million ≈ $78.66 Million	+109.43%
2016-12-31	CN¥256.69 Million ≈ $37.56 Million	+15.36%
2015-12-31	CN¥222.51 Million ≈ $32.56 Million	+5.50%
2014-12-31	CN¥210.90 Million ≈ $30.86 Million	+25.11%
2013-12-31	CN¥168.57 Million ≈ $24.67 Million	+38.88%
2012-12-31	CN¥121.38 Million ≈ $17.76 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Jiangsu Nanfang Medical's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 1140.1% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	CN¥289.04 Million	103.49%
Other Comprehensive Income	CN¥42.23 Million	15.12%
Other Components	CN¥106.24 Million	38.04%
Total Equity	CN¥279.29 Million	100.00%

Jiangsu Nanfang Medical Competitors by Market Cap

The table below lists competitors of Jiangsu Nanfang Medical ranked by their market capitalization.

Company	Market Cap
Sesoda Corp TW:1708	$315.37 Million
Kung Long Batteries Industrial Co Ltd TW:1537	$315.42 Million
Hubtown Limited NSE:HUBTOWN	$315.44 Million
Ercros MC:ECR	$315.45 Million
Perpetual Credit Income Trust AU:PCI	$314.92 Million
Spire Global Inc NYSE:SPIR	$314.78 Million
Alico Inc NASDAQ:ALCO	$314.69 Million
Precious Shipping Public Company Limited BK:PSL	$314.68 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Jiangsu Nanfang Medical's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 469,268,077 to 279,286,644, a change of -189,981,433 (-40.5%).
Net loss of 190,668,979 reduced equity.
Dividend payments of 27,079,802 reduced retained earnings.
Share repurchases of 18,601,440 reduced equity.
Other comprehensive income increased equity by 41,866,199.
Other factors increased equity by 4,502,589.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CN¥-190.67 Million	-68.27%
Dividends Paid	CN¥27.08 Million	-9.7%
Share Repurchases	CN¥18.60 Million	-6.66%
Other Comprehensive Income	CN¥41.87 Million	+14.99%
Other Changes	CN¥4.50 Million	+1.61%
Total Change	CN¥-	-40.48%

Book Value vs Market Value Analysis

This analysis compares Jiangsu Nanfang Medical's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 7.71x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 13.06x to 7.71x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2012-12-31	CN¥0.57	CN¥7.45	x
2013-12-31	CN¥0.79	CN¥7.45	x
2014-12-31	CN¥0.98	CN¥7.45	x
2015-12-31	CN¥1.03	CN¥7.45	x
2016-12-31	CN¥1.18	CN¥7.45	x
2017-12-31	CN¥2.24	CN¥7.45	x
2018-12-31	CN¥1.93	CN¥7.45	x
2019-12-31	CN¥1.98	CN¥7.45	x
2020-12-31	CN¥2.38	CN¥7.45	x
2021-12-31	CN¥2.22	CN¥7.45	x
2022-12-31	CN¥2.13	CN¥7.45	x
2023-12-31	CN¥1.62	CN¥7.45	x
2024-12-31	CN¥0.97	CN¥7.45	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Jiangsu Nanfang Medical utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -68.27%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -31.64%
• Asset Turnover: 0.57x
• Equity Multiplier: 3.78x
Recent ROE (-68.27%) is below the historical average (4.35%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2012	29.47%	8.42%	1.12x	3.13x	CN¥23.63 Million
2013	28.50%	9.41%	1.37x	2.21x	CN¥31.19 Million
2014	25.48%	11.36%	1.08x	2.09x	CN¥32.43 Million
2015	23.20%	11.83%	0.91x	2.14x	CN¥29.16 Million
2016	20.55%	11.70%	0.86x	2.04x	CN¥26.68 Million
2017	8.95%	9.74%	0.59x	1.55x	CN¥-5.58 Million
2018	7.05%	8.18%	0.57x	1.52x	CN¥-16.42 Million
2019	4.97%	5.71%	0.57x	1.54x	CN¥-28.36 Million
2020	14.07%	9.14%	1.00x	1.54x	CN¥28.39 Million
2021	-3.55%	-4.37%	0.43x	1.90x	CN¥-88.02 Million
2022	-2.42%	-2.74%	0.37x	2.36x	CN¥-76.60 Million
2023	-31.41%	-24.57%	0.47x	2.72x	CN¥-194.34 Million
2024	-68.27%	-31.64%	0.57x	3.78x	CN¥-218.60 Million

Industry Comparison

This section compares Jiangsu Nanfang Medical's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

Industry: Medical Instruments & Supplies
Average net assets among peers: $934,413,263
Average return on equity (ROE) among peers: 16.26%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Jiangsu Nanfang Medical (603880)	CN¥259.57 Million	29.47%	2.83x	$315.10 Million
Beijing Centergate Technologies Holding Co Ltd (000931)	$395.47 Million	15.97%	2.66x	$523.48 Million
Blue Sail Medical Co Ltd (002382)	$1.43 Billion	14.06%	0.29x	$1.10 Billion
Andon Health Co Ltd (002432)	$119.28 Million	36.81%	0.27x	$5.00 Billion
Allmed Medical Products Co Ltd Class A (002950)	$742.08 Million	26.74%	1.36x	$1.28 Billion
Guangzhou Improve Med Instrument (300030)	$954.18 Million	3.19%	0.54x	$376.43 Million
QITIAN Technology Group Co Ltd (300061)	$64.46 Million	19.72%	1.76x	$924.78 Million
Shanghai Tofflon Science Tech (300171)	$2.68 Billion	12.53%	0.56x	$1.47 Billion
Truking Technology Ltd (300358)	$2.39 Billion	1.73%	0.74x	$1.02 Billion
Jiangxi Sanxin Medtec Co Ltd (300453)	$207.61 Million	23.43%	0.59x	$770.09 Million
Shenyang Xingqi Pharmaceutical Co Ltd (300573)	$367.81 Million	8.43%	0.82x	$2.50 Billion

About Jiangsu Nanfang Medical

SHG:603880 China Medical Instruments & Supplies

Market Cap

$315.10 Million

CN¥2.15 Billion CNY

Market Cap Rank

#14759 Global

#4580 in China

Share Price

CN¥7.45

Change (1 day)

+4.78%

52-Week Range

CN¥5.30 - CN¥7.45

All Time High

CN¥16.80